The impact of phone counseling on urinary stone prevention

Author(s):  
Amihay Nevo ◽  
Karen L. Stern ◽  
Jonathan P. Moore ◽  
Mitchell R. Humphreys ◽  
Mark D. Tyson ◽  
...  
2020 ◽  
Vol 721 ◽  
pp. 137769
Author(s):  
Yanxin Wang ◽  
Quanrong Wang ◽  
Yamin Deng ◽  
Zhao Chen ◽  
Philippe Van Cappellen ◽  
...  

2021 ◽  
Vol 31 ◽  
pp. S22
Author(s):  
S. Anderson ◽  
D. McNicholas ◽  
C. Murphy ◽  
I. Cheema ◽  
L. McLornan ◽  
...  

Author(s):  
Anoush Azarfar ◽  
Zahra Rafiee ◽  
Yalda Ravanshad ◽  
Niloufar Saber Moghadam ◽  
Elham Bakhtiari

Context: The study aimed to systematically review the clinical data on the efficacy of Cystone® as an herbal treatment for urolithiasis. Methods: Full text randomized clinical trials comparing Cystone® with placebo or citrate in patients with urolithiasis for urinary stone prevention or treatment were evaluated. Three databases, including PubMed, Scopus, and Cochrane Library, were searched from January 2000 to December 2017. The main outcomes were the reductions in calculi number/size and urinary excretion rate of calcium, oxalate, and urate. The secondary outcome was the adverse effects of Cystone®. Documents were screened by two reviewers for eligibility. The Jadad score was used for quality assessment. The data were analyzed using the comprehensive meta-analysis version 2.2.064 software. Results: Of 532 relevant studies, five were finally included. Cystone® was effective in the decrement of stone size in comparison with placebo (95% CI: 0.63, 9.13). There was a significant difference in the excretion rate of uric acid but not calcium compared to the placebo. Cystone® had no significant side effects. Conclusions: Cystone® is more effective than a placebo in the treatment of urinary tract stones. It significantly induces stone size decrement and clearance compared to placebo. The low quality of reports is a major limitation in the applicability of these results.


2014 ◽  
Vol 191 (4S) ◽  
Author(s):  
Jack Lambert ◽  
Justin Watson ◽  
Nicole Miller ◽  
Shaun Wason ◽  
Michael Fabrizio ◽  
...  

Author(s):  
Steven Anderson ◽  
Daniel McNicholas ◽  
Claudine Murphy ◽  
Ijaz Cheema ◽  
Liza McLornan ◽  
...  

2018 ◽  
Vol 33 (2) ◽  
pp. 183-190 ◽  
Author(s):  
Amy N. Kerr ◽  
Barbara A. Schillo ◽  
Paula A. Keller ◽  
Randi B. Lachter ◽  
Rebecca K. Lien ◽  
...  

Purpose: To examine 2-week nicotine replacement therapy (NRT) starter kit quit outcomes and predictors and the impact of adding this new service on treatment reach. Design: Observational study of a 1-year cohort of QUITPLAN Services enrollees using registration and utilization data and follow-up outcome survey data of a subset of enrollees who received NRT starter kits. Setting: ClearWay Minnesota’s QUITPLAN Services provides a quit line that is available to uninsured and underinsured Minnesotans and NRT starter kits (a free 2-week supply of patches, gum, or lozenges) that are available to all Minnesota tobacco users. Participants: A total of 15 536 adult QUITPLAN Services enrollees and 818 seven-month follow-up survey NRT starter kit respondents. Measures: Treatment reach for all services and tobacco quit outcomes and predictors for starter kit recipients. Analysis: Descriptive analyses, χ2 analyses, and logistic regression. Results: Treatment reach increased 3-fold after adding the 2-week NRT starter kit service option to QUITPLAN Services compared to the prior year (1.86% vs 0.59%). Among all participants enrolling in QUITPLAN services during a 1-year period, 83.8% (13 026/15 536) registered for a starter kit. Among starter kit respondents, 25.6% reported being quit for 30 days at the 7-month follow-up. After controlling for other factors, using all NRT and selecting more cessation services predicted quitting. Conclusion: An NRT starter kit brought more tobacco users to QUITPLAN services, demonstrating interest in cessation services separate from phone counseling. The starter kit produced high quit rates, comparable to the quit line in the same time period. Cessation service providers may want to consider introducing starter kits to reach more tobacco users and ultimately improve population health.


2005 ◽  
Vol 4 (3) ◽  
pp. 262
Author(s):  
R. Autorino ◽  
M. De Sio ◽  
R. Damiano ◽  
L. Cosentino ◽  
U. Pane ◽  
...  

2012 ◽  
Vol 2 (1) ◽  
pp. 17-20 ◽  
Author(s):  
Yigit Akin ◽  
Selcuk Yucel ◽  
Ahmet Danisman ◽  
Tibet Erdogru ◽  
Mehmet Baykara

Introduction: Urinary stone disease is a common urologic problem and recurrence in stone formation is a very familiar issue to urologists. Although recurrence in stone formation has been linked to metabolic abnormalities, it can be accessible by metabolic risk analysis studies.Methods: Herein, we present our experience in metabolic risk management on recurrence of urinary stones for 10 years in Akdeniz University School of Medicine department of Urology. We retrospectively analyzed Akdeniz University Urinary Stone Database between dates of January 2000 and December 2010. We found over 3500 patients who were managed by SWL (shock wave lithotripsy) or PCNL (percutaneus nephrolithotripsy) or URS (Ureterorenoscopic lithotripsy) or open surgery.Results: 525 patients’ metabolic risk analysis was ordered due to recurrent urinary stone disease. Only 134 (25.5 %) current metabolic analysis were returned. Mean patient age was 32.2 years (range: 19-82 years).Patients were 103 male and 31 female. Stone analysis results were CaOx monohydrate in 48 (35.8 %), CaOx dihydrate in 8 (5.9 %), CaOx mono and dihydrate in 70 (52.2 %), uric acid in 3, CaOx monohydrate and uricacid in 2, cystine in 2, and struvite in 1 patient, respectively. The  metabolic risk analysis showed some abnormality in 54 (40.2 %) patients.Conclusion: Although compliance to metabolic risk analysis studies is low among recurrent urinary stone formers, some significant metabolic abnormalities could be detected in those who are effectively screened.Recurrence of urinary stones in patients who are started on appropriate metabolic management can be prevented.


1962 ◽  
Vol 14 ◽  
pp. 415-418
Author(s):  
K. P. Stanyukovich ◽  
V. A. Bronshten

The phenomena accompanying the impact of large meteorites on the surface of the Moon or of the Earth can be examined on the basis of the theory of explosive phenomena if we assume that, instead of an exploding meteorite moving inside the rock, we have an explosive charge (equivalent in energy), situated at a certain distance under the surface.


Sign in / Sign up

Export Citation Format

Share Document